首页/数据集/Additional file 5 of Patient preferences for pancreatic cancer treatment (PERSEUS): a multicenter discrete choice experiment

Additional file 5 of Patient preferences for pancreatic cancer treatment (PERSEUS): a multicenter discrete choice experiment

NIAID Data Ecosystem2026-05-10 收录

患者偏好研究

胰腺癌治疗

数据链接：

https://figshare.com/articles/dataset/Additional_file_5_of_Patient_preferences_for_pancreatic_cancer_treatment_PERSEUS_a_multicenter_discrete_choice_experiment/30948017 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Material 5

应用场景：

创建时间：

2025-12-24

辅助生殖技术

患者偏好研究

The preference of patients in the choice of pen injectors for Assisted Reproduction Technology (ART) is an important issue for treatment adherence. This study, based on discrete choice experiment (DCE

DataCite Commons2024-12-30 更新80

Clinical outcomes of patients with pancreatic tumors discussed in Tumor Board

胰腺癌治疗

多学科肿瘤委员会决策评估

ABSTRACT Objective: the recommendations of the decisions made by the Tumor Board (TB) should be followed to identify barriers that may interfere with the execution of the previously decided, best care

Figshare2022-06-01 更新40

Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer

胰腺癌治疗

铜配合物生物成像

Anticancer agents that present nonapoptotic cell death pathways are required for treating apoptosis-resistant pancreatic cancer. Here, we synthesized three fluorescent dithiocarbazate–copper complexes

NIAID Data Ecosystem40

Supplementary Material for: Sustained clinical response to Olaparib in a patient with metastatic pancreatic cancer and somatic ATM-Mutation R2034Ter: a case report

胰腺癌治疗

PARP1抑制剂治疗

Background Pancreatic cancer remains a lethal disease with limited therapeutic options. The field of targeted therapies is still growing. Treatment with PARP inhibitors has been successfully described

DataCite Commons2025-06-01 更新80

Table_5_Third-line treatment options in metastatic pancreatic cancer patients: a real-world study.xlsx

胰腺癌治疗

真实世界疗效比较

BackgroundThere are currently no standard therapy regimens for the third-line treatment of metastatic pancreatic cancer (mPC) patients. The aim of the present study was to compare the efficacy and saf

NIAID Data Ecosystem40

Additional file 5 of Patient preferences for pancreatic cancer treatment (PERSEUS): a multicenter discrete choice experiment

资源简介：

相关数据集